Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Korea Business Times.
Press releases published on May 8, 2025

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems
MINNEAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced a meaningful step forward for children facing fluid overload …

OTC Markets Group Welcomes Black Swan Graphene Inc. to OTCQX
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Black Swan Graphene Inc. (“Black Swan”) (TSX-V: SWAN; OTCQX: BSWGF), a …

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat rheumatoid arthritis to initiate in Q2 2025 CLN-978 expands into Sjögren’s disease; Phase 1 study in active, moderate to severe patients …

Microbix Schedules Release of Results for Q2 Fiscal 2025
MISSISSAUGA, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure …

Peloton Interactive, Inc. Reports Third Quarter Fiscal 2025 Financial Results
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (Nasdaq: PTON) has announced its financial results for the third quarter of fiscal 2025. Please visit the Peloton investor relations website to view the shareholder letter. Today, the …

Berry Corporation Reports First Quarter 2025 Financial and Operational Results, Reaffirms FY25 Guidance and Announces Quarterly Dividend
DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) today announced its financial and operational results for the first quarter of 2025, as well as a quarterly cash dividend of $0.03 per share. Berry …

Tecnoglass Reports Record First Quarter 2025 Results
- Record First Quarter Revenue of $222.3 Million, Up 15.4% Year-Over-Year Driven Entirely by Double Digit Organic Growth in Both Residential and Multi-Family/Commercial Projects - - Single-Family Residential Revenue Increased to a First Quarter Record $88. …

Lee Enterprises Reports Second Quarter Results
Total Digital Revenue(1) of $73M represented 53% of total revenue Digital-Only subscription revenue increased 20% YOY(2) Amplified Digital® Agency revenue totaled $25M, or up 9% YOY(2) DAVENPORT, Iowa, May 08, 2025 (GLOBE NEWSWIRE) -- Lee Enterprises, …

Zoomcar Announces Trading on OTCQX Best Market
Bangalore, India, May 08, 2025 (GLOBE NEWSWIRE) -- Zoomcar Holdings, Inc. (“Zoomcar” or the “Company”) (OTCQX: ZCAR), a leading marketplace for self-drive car sharing in India, announced that its common shares and warrants are transitioning from the Nasdaq …

Cielo Issues Letter to Shareholders
CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV: CMC; OTC PINK: CWSFF) (“Cielo” or the “Company”) is pleased to have issued today a letter to shareholders, as below: Dear Shareholders, Thank you to all those who …

Akebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
Strong initial quarter of Vafseo® (vadadustat) U.S. product launch, with Vafseo net product revenues of $12.0 million in Q1 2025 Total Q1 2025 net product revenues of $55.8 million Bolstered balance sheet and expanded institutional investor ownership …

Ligand Reports First Quarter 2025 Financial Results
First quarter performance driven by strong portfolio royalty revenue growth of 44% Strengthened commercial portfolio and pipeline through strategic transactions with Channel Therapeutics and Castle Creek Biosciences Reiterating 2025 financial guidance of $ …

Syndax Announces Participation in May Investor Conferences
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as …

Aptose Reports First Quarter 2025 Results
SAN DIEGO and TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat …

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update
RAP-219 Phase 2a trial in patients with refractory focal epilepsy remains on track with topline results expected in the third quarter of 2025 RAP-219 Phase 2a trial in patients with bipolar mania remains on track to commence in the third quarter of 2025, …

Lifetime Brands, Inc. Reports First Quarter 2025 Financial Results
Sales of $140.1 million TTM Adjusted EBITDA of $51.0 million Project Concord on Track to Deliver International Business Turnaround GARDEN CITY, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, …

Americold Announces First Quarter 2025 Results
Delivered $0.34 AFFO per share Completed Houston Warehouse Acquisition Enabling a Significant New Retail Customer Win Increased Quarterly Dividend by 5% Updated 2025 Full-Year Outlook ATLANTA, GA, May 08, 2025 (GLOBE NEWSWIRE) -- Americold Realty Trust, …

Entrada Therapeutics Reports First Quarter 2025 Financial Results
– Receives regulatory authorization in the EU for ELEVATE-44-201, a Phase 1/2 MAD clinical study of ENTR-601-44 in patients living with Duchenne muscular dystrophy who are amenable to exon 44 skipping – – Company remains on track to initiate ELEVATE-44-201 …

Talen Energy Reports First Quarter 2025 Results, Affirms and Narrows 2025 Guidance
Earnings Release Highlights First quarter GAAP Net Income (Loss) Attributable to Stockholders of $(135) million. First quarter Adjusted EBITDA of $200 million and Adjusted Free Cash Flow of $87 million, ahead of internal estimates. Affirming and narrowing …

Verano Announces First Quarter 2025 Financial Results
CHICAGO, May 08, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced its financial results for the first quarter ended March 31, 2025, which were …